Cargando…

Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test

AIM: DPP4 inhibitors are widely prescribed as treatments for type 2 diabetes. Because drug responses vary among individuals, we initiated investigations to identify genetic variants associated with the magnitude of drug responses. METHODS: Sitagliptin (100 mg) was administered to 47 healthy voluntee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beitelshees, Amber L., Streeten, Elizabeth A., Yazdi, Zhinous Shahidzadeh, Whitlatch, Hilary B., Mitchell, Braxton D., Shuldiner, Alan R., Montasser, May E., Taylor, Simeon I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557823/ https://www.ncbi.nlm.nih.gov/pubmed/37808823 http://dx.doi.org/10.1101/2023.09.24.23296026

Ejemplares similares

Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker
por: Taylor, Simeon I., et al.
Publicado: (2023)

Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectiveness
por: Taylor, Simeon I., et al.
Publicado: (2023)

Vitamin D deficiency increases vulnerability to canagliflozin-induced adverse effects on 1,25-dihydroxyvitamin D and PTH
por: Yazdi, Zhinous Shahidzadeh, et al.
Publicado: (2023)

THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023)

Clinical impact of recent genetic discoveries in osteoporosis
por: Mitchell, Braxton D, et al.
Publicado: (2013)

Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
por: Beitelshees, Amber L., et al.
Publicado: (2019)

Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY
por: Guida, Claudia, et al.
Publicado: (2017)

Efficacy and tolerability of sitagliptin and metformin compared with insulin as an initial therapy for newly diagnosed diabetic patients with severe hyperglycaemia
por: He, Mingqian, et al.
Publicado: (2021)

Regional Variations of Insulin Secretion and Insulin Sensitivity in Japanese Participants With Normal Glucose Tolerance
por: Watanabe, Kiriko, et al.
Publicado: (2021)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Insulin secretion and insulin resistance in Korean women with gestational diabetes mellitus and impaired glucose tolerance
por: Yang, Sae Jeong, et al.
Publicado: (2013)

Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2012)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Micromanaging Glucose Tolerance and Diabetes
por: Saliani, Negar, et al.
Publicado: (2017)

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013)

Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
por: Kutoh, Eiji
Publicado: (2011)

Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data
por: Murai, Kazuki, et al.
Publicado: (2014)

Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans
por: Tong, Jenny, et al.
Publicado: (2010)

KCNQ1 and Long QT Syndrome in 1/45 Amish: The Road From Identification to Implementation of Culturally Appropriate Precision Medicine
por: Streeten, Elizabeth A., et al.
Publicado: (2020)

Role of the Transcription Factor Sox4 in Insulin Secretion and Impaired Glucose Tolerance
por: Goldsworthy, Michelle, et al.
Publicado: (2008)

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
por: Williams-Herman, Debora, et al.
Publicado: (2008)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion
por: Remsberg, Jarrett R., et al.
Publicado: (2016)

Natural History of Insulin Sensitivity and Insulin Secretion in the Progression From Normal Glucose Tolerance to Impaired Fasting Glycemia and Impaired Glucose Tolerance: The Inter99 Study
por: Færch, Kristine, et al.
Publicado: (2009)

Associations Between Glucose Tolerance, Insulin Secretion, Muscle and Fat Mass in Cystic Fibrosis
por: Nielsen, Bibi Uhre, et al.
Publicado: (2021)

MON-500 A Case of Tumor-Induced Osteomalacia Caused by Metastatic Prostate Cancer
por: Rahman, Wedad, et al.
Publicado: (2019)

SAT245 Hips Don’t Lie: A Case Of Peri-Prosthetic Pseudotumor Leading To Hypercalcemia After Total Hip Replacement.
por: Sotomayor, Fiorella, et al.
Publicado: (2023)

Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance
por: Osei, Elizabeth, et al.
Publicado: (2021)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
por: Engel, Samuel S., et al.
Publicado: (2013)

The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin
por: Cengiz, Eda, et al.
Publicado: (2012)

An Amish founder population reveals rare-population genetic determinants of the human lipidome
por: Montasser, May E., et al.
Publicado: (2022)

Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance
por: Kaku, K., et al.
Publicado: (2015)

Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
por: Martin, Delphine, et al.
Publicado: (2008)

OR31-05 Long-Term Effects Of Gender Affirming Hormone Therapy On Insulin Sensitivity, Insulin Secretion, And Glucose Tolerance
por: Pinkson, Sheila, et al.
Publicado: (2023)

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
por: Perea, José Ramón Azanza, et al.
Publicado: (2022)

MON-327 A Case of Parathyroid Carcinoma in a Patient with Late Stage Chronic Kidney Disease
por: Frunza-Stefan, Simona, et al.
Publicado: (2019)

PSUN253 Cocaine Use Resulting in Inadvertent Sulfonylurea Overdose
por: Gothong, Chikara, et al.
Publicado: (2022)

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
por: Cho, Yong Kyun
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6c7rb9jpmtvmdpcr7t0g6mvfjj